問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberI8F-MC-GPGN
Completed

2020-05-29 - 2025-06-12

Phase III

Recruiting9

  • Trial Applicant

    ELI LILLY AND COMPANY(TAIWAN), INC.

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/04/01

Investigators and Locations

Principal Investigator Shih-Hsien Sung Division of Cardiovascular Diseases

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator I-TE LEE Division of Endocrinology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator I-Chang Hsieh Division of Cardiovascular Diseases

Co-Principal Investigator

  • 謝明哲 Division of Cardiovascular Diseases
  • 陳俊吉 Division of Cardiovascular Diseases
  • 葉日凱 Division of Cardiovascular Diseases
  • 陳東藝 Division of Cardiovascular Diseases
  • 王朝永 Division of Cardiovascular Diseases
  • 何明昀 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 杜思德 Division of Endocrinology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Ting-Hsing Chao Division of Cardiovascular Diseases

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 陳榮福 Division of Endocrinology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 劉銘恩 Division of Cardiovascular Diseases

Co-Principal Investigator

  • 林柏霖 Division of Cardiovascular Diseases
  • 吳敘平 Division of Cardiovascular Diseases
  • 賴堯暉 Division of Cardiovascular Diseases
  • 楊翔惟 Division of Cardiovascular Diseases
  • 劉俞旻 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 王志鴻 Division of Cardiovascular Diseases

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    90-180 participants

  • Global

    13299 participants